State Street Corp Atea Pharmaceuticals, Inc. Transaction History

State Street Corp

  • $2.8 Trillion
  • Q3 2025

A detailed history of State Street Corp transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 1,783,976 shares of AVIR stock, worth $5.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,783,976
Previous 1,776,401 0.43%
Holding current value
$5.28 Million
Previous $6.4 Million 19.11%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$2.88 - $3.9 $21,816 - $29,542
7,575 Added 0.43%
1,783,976 $5.17 Million
Q2 2025

Aug 14, 2025
BUY
$2.55 - $3.6 $14,568 - $20,566
5,713 Added 0.32%
1,776,401 $6.4 Million
Q1 2025

May 15, 2025
SELL
$2.9 - $3.52 $44,631 - $54,172
-15,390 Reduced 0.86%
1,770,688 $5.29 Million
Q4 2024

Feb 14, 2025
BUY
$2.93 - $3.82 $154,094 - $200,901
52,592 Added 3.03%
1,786,078 $5.98 Million
Q3 2024

Nov 14, 2024
BUY
$3.17 - $4.02 $36,664 - $46,495
11,566 Added 0.67%
1,733,486 $5.81 Million
Q2 2024

Aug 14, 2024
BUY
$3.31 - $4.04 $144,107 - $175,889
43,537 Added 2.59%
1,721,920 $5.7 Million
Q1 2024

May 15, 2024
BUY
$3.09 - $4.56 $149,389 - $220,457
48,346 Added 2.97%
1,678,383 $6.78 Million
Q4 2023

Feb 14, 2024
BUY
$2.8 - $3.35 $346,640 - $414,730
123,800 Added 8.22%
1,630,037 $4.97 Million
Q3 2023

Nov 14, 2023
SELL
$3.0 - $3.79 $81,153 - $102,523
-27,051 Reduced 1.76%
1,506,237 $4.52 Million
Q2 2023

Aug 14, 2023
SELL
$3.21 - $5.06 $1.06 Million - $1.67 Million
-330,049 Reduced 17.71%
1,533,288 $5.73 Million
Q1 2023

May 15, 2023
SELL
$3.0 - $4.97 $223,179 - $369,733
-74,393 Reduced 3.84%
1,863,337 $6.24 Million
Q4 2022

Feb 14, 2023
BUY
$4.35 - $6.17 $187,023 - $265,272
42,994 Added 2.27%
1,937,730 $9.32 Million
Q3 2022

Nov 15, 2022
BUY
$5.49 - $8.79 $501,610 - $803,124
91,368 Added 5.07%
1,894,736 $10.8 Million
Q2 2022

Aug 15, 2022
SELL
$5.33 - $8.18 $366,202 - $562,015
-68,706 Reduced 3.67%
1,803,368 $12.8 Million
Q1 2022

May 16, 2022
SELL
$5.5 - $9.19 $2.49 Million - $4.17 Million
-453,379 Reduced 19.5%
1,872,074 $13.5 Million
Q4 2021

Feb 14, 2022
BUY
$7.67 - $44.59 $9.38 Million - $54.5 Million
1,222,601 Added 110.86%
2,325,453 $20.8 Million
Q3 2021

Nov 15, 2021
BUY
$21.33 - $35.06 $3.01 Million - $4.95 Million
141,085 Added 14.67%
1,102,852 $38.7 Million
Q2 2021

Aug 16, 2021
BUY
$19.22 - $59.08 $13 Million - $40 Million
677,244 Added 238.03%
961,767 $20.7 Million
Q1 2021

May 17, 2021
BUY
$41.42 - $88.44 $2.56 Million - $5.47 Million
61,849 Added 27.78%
284,523 $17.6 Million
Q4 2020

Feb 16, 2021
BUY
$26.36 - $41.78 $5.87 Million - $9.3 Million
222,674 New
222,674 $9.3 Million

Others Institutions Holding AVIR

# of Institutions
123
Shares Held
49.3M
Call Options Held
54K
Put Options Held
98K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $246M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email